Brian G. Feagan, Gordon R. Greenberg, Gary Wild, Richard N

Slides:

Advertisements

Similar presentations

Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.

Advertisements

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease Richard N. Fedorak, *, Alfred Gangl, ‡, Charles.

The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States Michael D. Kappelman, Sheryl L. Rifas–Shiman,

The Role of Psychosocial Care in Adapting to Health Care Reform

Abnormal Liver Tests and Fatty Liver on Ultrasound

Thrombocytopenia With Abnormal Liver Function Tests

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

Saurabh Dawra, Vishal Sharma, Usha Dutta

Volume 146, Issue 3, Pages e1 (March 2014)

Nitsan Maharshak, Scott E. Plevy

Volume 135, Issue 4, Pages (October 2008)

Shou–Jiang Tang, Feriyl Bhaijee

Gauree Gupta, Ebbing Lautenbach, James D. Lewis

Celiac Disease and Persistent Symptoms

Katsunori Matsueda, Tatsuya Toyokawa

Right Upper Quadrant Pain and a Normal Abdominal Ultrasound

A Randomized, Double-Masked, Placebo-Controlled Study of Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule 1, for the Treatment of.

The Probiotic VSL#3 Has Anti-inflammatory Effects and Could Reduce Endoscopic Recurrence After Surgery for Crohn's Disease Richard N. Fedorak, Brian.

Rebekah S. Wieland, Richard S. Zubarik, Maryam J. Zenali

Stephen A. Harrison, MD, FACP Clinical Gastroenterology and Hepatology

A 5-Year Prospective Observational Study of the Outcomes of International Treatment Guidelines for Crohn's Disease Garret Cullen, Denise Keegan, Hugh.

Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen, Bruce A

Cecal Insertion and Withdrawal Times With Wide-Angle Versus Standard Colonoscopes: A Randomized Controlled Trial Hala Fatima, Douglas K. Rex, Richard.

Andree Koop, Michael J. Bartel, Dawn Francis

Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease Elana A. Maser, Renata Villela,

Jessica L. Mellinger, Michael L. Volk

Endoscopic Therapy for Barrett's Esophagus

Leon P. McLean, Jonathan S. Chun, Raymond K. Cross

A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab Fernando.

Volume 132, Issue 5, Pages (May 2007)

Abnormal Liver Tests and Fatty Liver on Ultrasound

William D. Leslie Clinical Gastroenterology and Hepatology

New Models of Gastroenterology Practice

William J. Sandborn, Stefan Schreiber, Brian G

Volume 119, Issue 6, Pages (December 2000)

Endoscopic Ultrasound–Guided Cholecystoduodenostomy for Acute Cholecystitis in a Patient With Thrombocytopenia and End-Stage Liver Disease Awaiting Transplantation

Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study Timna Naftali, Lihi Bar-Lev Schleider,

David H. Bruining, William J. Sandborn

Najat Mourra, Nikias Colignon Clinical Gastroenterology and Hepatology

Peter Bytzer Clinical Gastroenterology and Hepatology

Patient-Reported Outcomes of Cirrhosis

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Issue Highlights Clinical Gastroenterology and Hepatology

Alan Bonder, MD, Nezam H. Afdhal, MD

Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity Severine Vermeire, Stefan Schreiber,

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Thrombocytopenia With Abnormal Liver Function Tests

Volume 117, Issue 3, Pages (September 1999)

Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States Zobair M. Younossi, Maria Stepanova

Rocco Ricciardi, Robert D. Madoff, David A. Rothenberger, Nancy N

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Christopher Hung, Desmond Leddin

Coagulation in Liver Disease: A Guide for the Clinician

Issue Highlights Clinical Gastroenterology and Hepatology

Issue Highlights Clinical Gastroenterology and Hepatology

Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism? John S. Leeds, David S. Sanders

Issue Highlights Clinical Gastroenterology and Hepatology

Coloduodenal Fistula in Crohn’s Disease

Matthew J. Lee, Claire E. Parker, Sarah R

Rintaro Hashimoto, Akimichi Chonan

Adverse Outcomes: Why Bad Things Happen to Good People

The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States Michael D. Kappelman, Sheryl L. Rifas–Shiman,

Medical Therapy for Refractory Pediatric Crohn’s Disease

Issue Highlights Clinical Gastroenterology and Hepatology

Thomas G. Cotter, John S. Van Arnam, John A. Schaffner

Rintaro Hashimoto, Akimichi Chonan

The Role of Psychosocial Care in Adapting to Health Care Reform

Antimicrobial Antibodies Are Associated With a Crohn's Disease–Like Phenotype After Ileal Pouch–Anal Anastomosis Andrea D. Tyler, Raquel Milgrom, Wei.

Jordan E. Axelrad, Simon Lichtiger, Amrita Sethi

Choosing Wisely and the Perceived Drivers of Endoscopy Use

Presentation transcript:

Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin Brian G. Feagan, Gordon R. Greenberg, Gary Wild, Richard N. Fedorak, Pierre Paré, John W.D. McDonald, Albert Cohen, Alain Bitton, Jeffrey Baker, Réjean Dubé, Steven B. Landau, Margaret K. Vandervoort, Asit Parikh Clinical Gastroenterology and Hepatology Volume 6, Issue 12, Pages 1370-1377 (December 2008) DOI: 10.1016/j.cgh.2008.06.007 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Patient disposition. Clinical Gastroenterology and Hepatology 2008 6, 1370-1377DOI: (10.1016/j.cgh.2008.06.007) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 Proportions of patients achieving (A) clinical response (≥70-point decrement in CDAI from baseline) and (B) clinical remission (CDAI ≤150) over the course of the study. *P value less than .05 versus placebo. Clinical Gastroenterology and Hepatology 2008 6, 1370-1377DOI: (10.1016/j.cgh.2008.06.007) Copyright © 2008 AGA Institute Terms and Conditions